Bionano Genomics Inc.

NASDAQ: BNGO · Real-Time Price · USD
3.02
-0.19 (-5.92%)
At close: Aug 15, 2025, 12:39 PM

Bionano Genomics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
9.17M 17.95M 5.09M 24.57M
Short-Term Investments
302K 48.82M 108.09M 226.04M
Long-Term Investments
n/a 400K 400K n/a
Other Long-Term Assets
3.15M 7.43M 2.81M 749K
Receivables
4.77M 9.66M 7.02M 5.32M
Inventory
11.12M 22.89M 29.76M 12.39M
Other Current Assets
12.32M 36.09M 5.94M 1.38M
Total Current Assets
39.49M 140.12M 157.3M 272.41M
Property-Plant & Equipment
24.32M 32.48M 28.96M 20.93M
Goodwill & Intangibles
9.71M 33.97M 118.43M 83M
Total Long-Term Assets
37.18M 74.29M 150.2M 104.69M
Total Assets
76.67M 214.4M 307.5M 377.1M
Account Payables
6.96M 10.38M 12.53M 9.7M
Deferred Revenue
1.13M 800K 871K 1.51M
Short-Term Debt
23.61M 69.8M 2.54M 1.77M
Other Current Liabilities
3.66M 13.96M 15.55M 6.02M
Total Current Liabilities
37.34M 100.03M 35.88M 21.84M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a 10.89M 12.97M 9.07M
Total Long-Term Liabilities
3.95M 18.22M 22.22M 18.14M
Total Liabilities
41.3M 118.25M 58.1M 39.98M
Total Debt
27.3M 79.41M 11.67M 10.7M
Common Stock
n/a 5K 30K 29K
Retained Earnings
-693.23M -581.21M -348.71M -216.12M
Comprehensive Income
27K 23K -1.12M -539K
Shareholders Equity
35.38M 96.16M 249.4M 337.12M
Total Investments
302K 48.82M 108.09M 226.04M